These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 22949699)
1. Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs. Adams DJ; Dai M; Pellegrino G; Wagner BK; Stern AM; Shamji AF; Schreiber SL Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15115-20. PubMed ID: 22949699 [TBL] [Abstract][Full Text] [Related]
2. Piperlongumine and some of its analogs inhibit selectively the human immunoproteasome over the constitutive proteasome. Bosc E; Nastri J; Lefort V; Valli M; Contiguiba F; Pioli R; Furlan M; Bolzani VDS; El Amri C; Reboud-Ravaux M Biochem Biophys Res Commun; 2018 Feb; 496(3):961-966. PubMed ID: 29355526 [TBL] [Abstract][Full Text] [Related]
3. Discovery of small-molecule enhancers of reactive oxygen species that are nontoxic or cause genotype-selective cell death. Adams DJ; Boskovic ZV; Theriault JR; Wang AJ; Stern AM; Wagner BK; Shamji AF; Schreiber SL ACS Chem Biol; 2013 May; 8(5):923-9. PubMed ID: 23477340 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents. Wu Y; Min X; Zhuang C; Li J; Yu Z; Dong G; Yao J; Wang S; Liu Y; Wu S; Zhu S; Sheng C; Wei Y; Zhang H; Zhang W; Miao Z Eur J Med Chem; 2014 Jul; 82():545-51. PubMed ID: 24937186 [TBL] [Abstract][Full Text] [Related]
5. Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer. Roh JL; Kim EH; Park JY; Kim JW; Kwon M; Lee BH Oncotarget; 2014 Oct; 5(19):9227-38. PubMed ID: 25193861 [TBL] [Abstract][Full Text] [Related]
6. Piperlongumine Analogs Promote A549 Cell Apoptosis through Enhancing ROS Generation. Sun AL; Mu WW; Li YM; Sun YL; Li PX; Liu RM; Yang J; Liu GY Molecules; 2021 May; 26(11):. PubMed ID: 34071298 [TBL] [Abstract][Full Text] [Related]
7. Horner-Wadsworth-Emmons approach to piperlongumine analogues with potent anti-cancer activity. Han LC; Stanley PA; Wood PJ; Sharma P; Kuruppu AI; Bradshaw TD; Moses JE Org Biomol Chem; 2016 Aug; 14(31):7585-93. PubMed ID: 27443386 [TBL] [Abstract][Full Text] [Related]
8. Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation. Liu X; Wang Y; Zhang X; Gao Z; Zhang S; Shi P; Zhang X; Song L; Hendrickson H; Zhou D; Zheng G Bioorg Med Chem; 2018 Aug; 26(14):3925-3938. PubMed ID: 29925484 [TBL] [Abstract][Full Text] [Related]
9. Identification of novel ROS inducer by merging the fragments of piperlongumine and dicoumarol. Xu X; Fang X; Wang J; Zhu H Bioorg Med Chem Lett; 2017 Mar; 27(5):1325-1328. PubMed ID: 28159415 [TBL] [Abstract][Full Text] [Related]
10. Novel non-trimethoxylphenyl piperlongumine derivatives selectively kill cancer cells. Zhang Y; Ma H; Wu Y; Wu Z; Yao Z; Zhang W; Zhuang C; Miao Z Bioorg Med Chem Lett; 2017 Jun; 27(11):2308-2312. PubMed ID: 28434764 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of N-heteroaromatic ring-based analogs of piperlongumine as potent anticancer agents. Zou Y; Yan C; Zhang H; Xu J; Zhang D; Huang Z; Zhang Y Eur J Med Chem; 2017 Sep; 138():313-319. PubMed ID: 28686911 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties. Punganuru SR; Madala HR; Venugopal SN; Samala R; Mikelis C; Srivenugopal KS Eur J Med Chem; 2016 Jan; 107():233-44. PubMed ID: 26599530 [TBL] [Abstract][Full Text] [Related]
13. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors. Karki K; Hedrick E; Kasiappan R; Jin UH; Safe S Cancer Prev Res (Phila); 2017 Aug; 10(8):467-477. PubMed ID: 28673967 [TBL] [Abstract][Full Text] [Related]
14. Piperlongumine derivative, CG-06, inhibits STAT3 activity by direct binding to STAT3 and regulating the reactive oxygen species in DU145 prostate carcinoma cells. Kim YH; Yoon YJ; Lee YJ; Kim CH; Lee S; Choung DH; Han DC; Kwon BM Bioorg Med Chem Lett; 2018 Aug; 28(14):2566-2572. PubMed ID: 29807795 [TBL] [Abstract][Full Text] [Related]
15. Piperlongumine treatment inactivates peroxiredoxin 4, exacerbates endoplasmic reticulum stress, and preferentially kills high-grade glioma cells. Kim TH; Song J; Kim SH; Parikh AK; Mo X; Palanichamy K; Kaur B; Yu J; Yoon SO; Nakano I; Kwon CH Neuro Oncol; 2014 Oct; 16(10):1354-64. PubMed ID: 24879047 [TBL] [Abstract][Full Text] [Related]
16. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Raj L; Ide T; Gurkar AU; Foley M; Schenone M; Li X; Tolliday NJ; Golub TR; Carr SA; Shamji AF; Stern AM; Mandinova A; Schreiber SL; Lee SW Nature; 2011 Jul; 475(7355):231-4. PubMed ID: 21753854 [TBL] [Abstract][Full Text] [Related]
17. Using Sensors and Generators of H2O2 to Elucidate the Toxicity Mechanism of Piperlongumine and Phenethyl Isothiocyanate. Huang BK; Langford TF; Sikes HD Antioxid Redox Signal; 2016 Jun; 24(16):924-38. PubMed ID: 26905788 [TBL] [Abstract][Full Text] [Related]
18. Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents (review). Möhler H; Pfirrmann RW; Frei K Int J Oncol; 2014 Oct; 45(4):1329-36. PubMed ID: 25175943 [TBL] [Abstract][Full Text] [Related]
19. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells. Zhang P; Shi L; Zhang T; Hong L; He W; Cao P; Shen X; Zheng P; Xia Y; Zou P Cell Oncol (Dordr); 2019 Dec; 42(6):847-860. PubMed ID: 31493144 [TBL] [Abstract][Full Text] [Related]
20. Piperlongumine Induces Apoptosis in Human Melanoma Cells Via Reactive Oxygen Species Mediated Mitochondria Disruption. Song X; Gao T; Lei Q; Zhang L; Yao Y; Xiong J Nutr Cancer; 2018 Apr; 70(3):502-511. PubMed ID: 29543494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]